FDA Inside Trader Latest Example of SEC Crackdown
By VFC’s Stock House When someone is given a position of great power or responsibility – or even just a low-key position on the inside as this one may have been – it’s expected by most others that the...
View ArticleCEL-SCI Corporation (AMEX:CVM): Phase III Ready To Go in Canada and India
By VFC’s Stock House The Multikine Phase III commencements and site approvals continued last week for Cel-Sci Corp. (AMEX:CVM), as the company issued consecutive press releases on Thursday and Friday...
View ArticleSearching for Innovative Small-Cap Biotech Companies with George Zavoico:...
By George S. Mack High-quality science underlies successful drug development companies, even those that turn one company’s discarded junk into biotech treasure. That’s an example of one compelling...
View ArticleStock Market Roundup: Ampio (AMPE) Slammed by The Mad Blogger, Spectrum...
By VFC’s Stock House Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE): TheStreet.com’s biotech blogger graced readers with an early edition of the Biotech Stock Mailbag this week, releasing it on Thursday...
View ArticleWeekly Stock Watch: AMPE, PBTH, IMUC, NBY, NRIFF, CNDO, SIGA, IMSC, YHOO, FB,...
By VFC’s Stock House At the conclusion of each week, VFC’s Stock House examines some news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or...
View ArticleWeekly Stock Watch: GOOG, FB, BAC, C, IMSC, DNDN, HGSI, AGEN, MNKD, PIMO,...
By VFC’s Stock House At the conclusion of each week, VFC’s Stock House examines some news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or...
View ArticleAmpio Pharmaceuticals (NASDAQ:AMPE): Positioned For A Rebound
By VFC’s Stock House After a five percent drop on Friday, shares of Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) started to rebound along with the broad markets on Monday, posting a three percent increase...
View ArticleStock Watch: Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) On The Move
By VFC’s Stock House A late day price and volume spike placed shares of Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) more than ten percent higher than where they opened on Wednesday, a notable feat on a...
View ArticleBuyout Talk, Catalysts and Clinical Results Can Move These Healthcare Stocks:...
By VFC’s Stock House Trial results, trial initiations, FDA approval filings, peer-reviewed validation and FDA approvals are all factors that play heavily into the trading patterns of biotech and...
View ArticleBiotechnology & Patents: Long-Term Security, Opportunity for Dominance and...
By The Swiss Trader Over the last six months the big topic in biotechnology has been the patent void that large pharma companies are currently facing. With the FDA approving fewer novel drugs in 2012...
View ArticleHealthcare Sector Notes: SPPI, GSK, ALTH, SSH, BSX, TROV, AMRN
By VFC’s Stock House The international markets received a nice boost this week as signs that the European economy would respond well to stimulus packages were noted while US productivity numbers were...
View ArticleWeekly Stock Watch: AAPL, GOOG, AMRN, SGYP, CLSP, BMY, IRWD, ADMD, ONTY,...
By VFC’s Stock House The markets finished last week on a strong note, even if a six week streak of gains was broken thanks to some mid-week downside volatility. Friday’s spike was born thanks to...
View ArticleWeekly Stock Watch: FB, IMSC, AMRN, SSH, NBS, ACTC, TROV, MNKD, ADMD, LPTN,...
By VFC’s Stock House The summer play period is over and even though the coming week will be shortened due to the Labor Day holiday, it’ll back to work for the masses come Tuesday morning — meaning...
View ArticleWeekly Stock Watch: AMRN, SGYP, IRWD, FRX, SSH, NBS, ACTC, AEZS, KERX, TTNP
By VFC’s Stock House The markets flew last Thursday afternoon and Friday morning after much-anticipated comments from the US Federal Reserve indicated that stimulus for the ailing economy would...
View ArticleThinkEquity Senior Research Analyst Kimberly Lee Bets on Extraordinary...
By George S. Mack Investing in companies devoted to orphan diseases sounds counterintuitive, but Senior Research Analyst Kimberly Lee of ThinkEquity has singled out the space as one with the potential...
View ArticleFinding a Micro-Cap Biotech Gem: ONCS, ALXA, BPAX, VTUS
By Amy Baldwin Take a moment to look and explore the website and/or reviews of any microcap biotechnology company and you’ll find that it’s not difficult to make a company in the space appear...
View ArticleOncoSec Medical Inc. (ONCS): Pushing the Limits of Cancer Treatment
By The Swiss Trader Recently, the San Francisco Chronicle carried a story about a promising treatment for melanoma at the University of California, San Francisco (UCSF). UCSF is one of three cancer...
View ArticleCan Investing in the Industry of Sweeteners Return Sweet Gains? (SNMX, PEP,...
By Henry Kawabe When one thinks of the sweetener business, sugar and artificial sweeteners, such as aspartame, are immediately focused on. However, there are other aspects to the business. A very...
View ArticleThree Biopharmaceutical Companies with Promising Cancer Therapies in Late...
By The Swiss Trader For 2012 the broader biotech indices, the NASDAQ Biotechnology Index (NBI) was up more than 30%, almost double the 15.9% rise in the S&P 500. The NBI has 117 companies, but...
View ArticleAs Stevia Expands in Popularity, 2013 Could be a Good Year for Growers,...
By Glen S. Woods Stevia, the zero calorie natural sugar substitute, continues to grow in popularity. According to Packaged Facts of the U.S, the 2011 world stevia market, retail and wholesale, was...
View ArticleSANUWAVE Health, Inc. (SNWV) Offers Investors Promise and Potential
By VFC’s Stock House SANUWAVE Health Inc. (OTC:SNWV), a company advancing a technology that could change the scope of chronic wound treatment for years to come, is sitting in the midst of a booming...
View ArticleSanuWave Health Inc. (SNWV) Boosts Long-Term Potential with Short-Term Catalysts
By VFC’s Stock House SANUWAVE Health Inc. (OTC:SNWV), with trial catalysts pending over the near term, has received its fair share of attention during the course of 2013 thus far, but the company’s...
View ArticleSpecialty Pharmacies Offer Solutions — Also For Investors: PMC, BIOS, APHY
By Dutch Trader In 2012, Americans filled more than 4 billion prescriptions at 62,000 retail, mail, and specialty pharmacies. The largest U.S. pharmacies ranked by total prescription you will find in...
View Article
